Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -1.32% | -10.24% | -44.44% |
05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-44.44% | 2.89M | |
-3.87% | 187B | |
-0.52% | 109B | |
-3.65% | 69.22B | |
-5.79% | 46.36B | |
+13.26% | 46.19B | |
+8.48% | 42.44B | |
+18.83% | 30.84B | |
+19.69% | 25.73B | |
-6.80% | 23.3B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Biosciences Announces the Appointment of Jeffrey J. Segal as a Director of the Company